Boehringer Ingelheim Reports Positive Phase II Res...
Category : Clinical Trial Update 30 January 2026Boehringer Ingelheim has reported positive results from a 12-week Phase II clinical trial evaluating...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Boehringer Ingelheim has reported positive results from a 12-week Phase II clinical trial evaluating...
Innovative Molecules GmbH, a German clinical-stage biotech company, has completed its Phase 1 clinic...
MicuRx Pharmaceuticals, Inc. has received U.S. FDA clearance for its Investigational New Drug (IND)...
Opus Genetics has announced the launch and funding of a clinical trial evaluating a gene therapy for...
Bayer will present new data and technology advancements from its comprehensive radiology portfolio a...